0,1,2,3,4,5,6,7
Table 4: Procedure-specific evidence summaries with recommendations for radical cystectomies,,,,,,,
Procedure,Outcome,Baseline risk   among 1000   patients,,Net benefit per   1000 patients   with pharma-  cological   prophylaxis*,Certainty   in   estimate,Recommendations   for  pharma cological    prophylaxis,Recommendations  for mechanical   prophylaxis
"Cystectomy,   Open",Venous   thrombo-  embolism,Low-risk,29,13,Moderate,"Strong, for","Weak, for"
,,Medium-   risk,58,27,High,"Strong, for","Weak, for"
,,High risk,116,56,High,"Strong, for","Weak, for"
,Bleeding  requiring   reoperation,,3.0,,Moderate/  High,,
"Cystectomy,   Robotic",Venous  thrombo-  embolism,Low-risk,26,11,Low,"Weak, for","Weak, for"
,,Medium-  risk,52,24,Low,"Weak, for","Weak, for"
,,High risk,103,50,Low,"Weak, for","Weak, for"
,Bleeding  requiring   reoperation,,3.0,,Low,,
